Amarin spurns would-be marketing partners to launch Vascepa in Europe on its own beth.bulik Tue, 08/04/2020 – 10:29
Category: Uncategorized
Novartis eyes 3rd Kymriah indication with follicular lymphoma trial win aliu Tue, 08/04/2020 – 11:48
When we get a wound on our skin, the cells in our bodies quickly mobilize to repair it. […]
Scientists in the Multiscale Bioimaging Cluster of Excellence have succeeded for the first time in simultaneously displaying the […]
New deal with Wockhardt boosts capacity at the crucial ‘fill and finish’ stage
Therapy has been approved to treat advanced NTRK fusion-positive solid tumours
Agreement will utilise Oxford Biomedica’s LentiVector platform
Drug approved to treat major depressive disorder with acute suicidal ideation or behaviour
Updated Date: Mon, 27 Jul 2020 00:00:00 EDT
